Protocol 2001133:..Study to Evaluate Efficacy and Safety of Transdermal Testosterone (300 ug/day) for 24 Weeks and Safety for a Further 28-Week Open-Label Period in Women with Hypoactive Sexual Desire Disorder on Concurrent Estrogen Replacement Therapy

  • Muse, Kenneth (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/16/024/30/07